nodes	percent_of_prediction	percent_of_DWPC	metapath
Paramethadione—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.219	0.228	CbGbCtD
Paramethadione—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.153	0.159	CbGbCtD
Paramethadione—CYP2C8—Progesterone—uterine cancer	0.145	0.151	CbGbCtD
Paramethadione—CYP2C9—Progesterone—uterine cancer	0.101	0.105	CbGbCtD
Paramethadione—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0888	0.0923	CbGbCtD
Paramethadione—CYP2E1—Etoposide—uterine cancer	0.0869	0.0903	CbGbCtD
Paramethadione—CYP2C8—Etoposide—uterine cancer	0.0649	0.0675	CbGbCtD
Paramethadione—CYP3A4—Progesterone—uterine cancer	0.0588	0.0612	CbGbCtD
Paramethadione—CYP3A4—Etoposide—uterine cancer	0.0263	0.0274	CbGbCtD
Paramethadione—CYP3A4—Doxorubicin—uterine cancer	0.018	0.0187	CbGbCtD
Paramethadione—CACNA1G—decidua—uterine cancer	0.00161	0.144	CbGeAlD
Paramethadione—CACNA1H—myometrium—uterine cancer	0.00142	0.127	CbGeAlD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—STAR—uterine cancer	0.00117	0.0434	CbGpPWpGaD
Paramethadione—CACNA1I—lymph node—uterine cancer	0.00108	0.0969	CbGeAlD
Paramethadione—CACNA1H—smooth muscle tissue—uterine cancer	0.00107	0.0963	CbGeAlD
Paramethadione—CACNA1I—Axon guidance—PLXNA3—uterine cancer	0.000925	0.0344	CbGpPWpGaD
Paramethadione—CACNA1H—uterus—uterine cancer	0.000921	0.0826	CbGeAlD
Paramethadione—CACNA1H—female reproductive system—uterine cancer	0.000828	0.0742	CbGeAlD
Paramethadione—CACNA1H—female gonad—uterine cancer	0.000753	0.0676	CbGeAlD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAE—uterine cancer	0.000707	0.0263	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—CYP11A1—uterine cancer	0.000697	0.026	CbGpPWpGaD
Paramethadione—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.000684	0.0255	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—PLXNA3—uterine cancer	0.000682	0.0254	CbGpPWpGaD
Paramethadione—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—uterine cancer	0.000665	0.0247	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—PLXNA3—uterine cancer	0.000661	0.0246	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—PLXNA3—uterine cancer	0.00066	0.0246	CbGpPWpGaD
Paramethadione—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.000527	0.0196	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—PLXNA3—uterine cancer	0.000487	0.0181	CbGpPWpGaD
Paramethadione—CACNA1H—lymph node—uterine cancer	0.000484	0.0434	CbGeAlD
Paramethadione—CACNA1H—Developmental Biology—PLXNA3—uterine cancer	0.000471	0.0175	CbGpPWpGaD
Paramethadione—CYP2C8—renal system—uterine cancer	0.000429	0.0385	CbGeAlD
Paramethadione—CYP2C8—endometrium—uterine cancer	0.000415	0.0372	CbGeAlD
Paramethadione—CYP2E1—renal system—uterine cancer	0.000361	0.0324	CbGeAlD
Paramethadione—CACNA1I—Developmental Biology—HNF1B—uterine cancer	0.000347	0.0129	CbGpPWpGaD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—uterine cancer	0.000344	0.0128	CbGpPWpGaD
Paramethadione—CYP2C8—female reproductive system—uterine cancer	0.000344	0.0308	CbGeAlD
Paramethadione—CACNA1I—NCAM signaling for neurite out-growth—NRAS—uterine cancer	0.000341	0.0127	CbGpPWpGaD
Paramethadione—CYP2C8—vagina—uterine cancer	0.000311	0.0279	CbGeAlD
Paramethadione—CYP2C9—female reproductive system—uterine cancer	0.000305	0.0274	CbGeAlD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—uterine cancer	0.000304	0.0113	CbGpPWpGaD
Paramethadione—CACNA1I—NCAM signaling for neurite out-growth—KRAS—uterine cancer	0.000294	0.0109	CbGpPWpGaD
Paramethadione—CYP3A4—renal system—uterine cancer	0.000291	0.0261	CbGeAlD
Paramethadione—CYP2E1—female reproductive system—uterine cancer	0.000289	0.026	CbGeAlD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—uterine cancer	0.000275	0.0102	CbGpPWpGaD
Paramethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000264	0.00981	CbGpPWpGaD
Paramethadione—CYP2E1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.00026	0.00968	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—HNF1B—uterine cancer	0.000256	0.00952	CbGpPWpGaD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—uterine cancer	0.000254	0.00946	CbGpPWpGaD
Paramethadione—CACNA1G—NCAM signaling for neurite out-growth—NRAS—uterine cancer	0.000252	0.00936	CbGpPWpGaD
Paramethadione—CACNA1I—NCAM signaling for neurite out-growth—HRAS—uterine cancer	0.00025	0.00929	CbGpPWpGaD
Paramethadione—CYP2C8—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000249	0.00926	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—HNF1B—uterine cancer	0.000248	0.00922	CbGpPWpGaD
Paramethadione—CACNA1H—NCAM signaling for neurite out-growth—NRAS—uterine cancer	0.000244	0.00907	CbGpPWpGaD
Paramethadione—CYP2E1—Tryptophan metabolism—CYP19A1—uterine cancer	0.00024	0.00893	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—CXCL8—uterine cancer	0.000239	0.00888	CbGpPWpGaD
Paramethadione—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—uterine cancer	0.000236	0.00879	CbGpPWpGaD
Paramethadione—CYP3A4—female reproductive system—uterine cancer	0.000233	0.0209	CbGeAlD
Paramethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000228	0.00848	CbGpPWpGaD
Paramethadione—CYP2C8—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000225	0.00837	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—CTNNB1—uterine cancer	0.00022	0.00819	CbGpPWpGaD
Paramethadione—CACNA1G—NCAM signaling for neurite out-growth—KRAS—uterine cancer	0.000217	0.00806	CbGpPWpGaD
Paramethadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000214	0.00795	CbGpPWpGaD
Paramethadione—CACNA1H—NCAM signaling for neurite out-growth—KRAS—uterine cancer	0.00021	0.00781	CbGpPWpGaD
Paramethadione—CYP2C9—Arachidonic acid metabolism—AKR1C3—uterine cancer	0.000203	0.00754	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000201	0.00749	CbGpPWpGaD
Paramethadione—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000194	0.00722	CbGpPWpGaD
Paramethadione—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000191	0.00712	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—AKR1B1—uterine cancer	0.000187	0.00696	CbGpPWpGaD
Paramethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000185	0.0069	CbGpPWpGaD
Paramethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000185	0.00687	CbGpPWpGaD
Paramethadione—CACNA1G—NCAM signaling for neurite out-growth—HRAS—uterine cancer	0.000184	0.00685	CbGpPWpGaD
Paramethadione—CYP2C9—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000183	0.00681	CbGpPWpGaD
Paramethadione—CACNA1H—NCAM signaling for neurite out-growth—HRAS—uterine cancer	0.000178	0.00663	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—MET—uterine cancer	0.000176	0.00655	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—AKR1B10—uterine cancer	0.000174	0.00647	CbGpPWpGaD
Paramethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000168	0.00624	CbGpPWpGaD
Paramethadione—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000165	0.00616	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—AKR1B1—uterine cancer	0.000162	0.00602	CbGpPWpGaD
Paramethadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000157	0.00585	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—SMAD3—uterine cancer	0.000153	0.0057	CbGpPWpGaD
Paramethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.00015	0.00559	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—AKR1B10—uterine cancer	0.000142	0.00527	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000137	0.00511	CbGpPWpGaD
Paramethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000136	0.00508	CbGpPWpGaD
Paramethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000136	0.00506	CbGpPWpGaD
Paramethadione—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000135	0.00501	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—AKR1B1—uterine cancer	0.000132	0.0049	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—MET—uterine cancer	0.00013	0.00483	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—ERBB2—uterine cancer	0.000129	0.00479	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—MET—uterine cancer	0.000126	0.00468	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—MET—uterine cancer	0.000126	0.00467	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—AKT1—uterine cancer	0.000124	0.0046	CbGpPWpGaD
Paramethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000122	0.00455	CbGpPWpGaD
Paramethadione—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000121	0.00449	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—GPX3—uterine cancer	0.000121	0.00449	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—AKR1C1—uterine cancer	0.000119	0.00442	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—CYP11A1—uterine cancer	0.000114	0.00422	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—SMAD3—uterine cancer	0.000113	0.00421	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—CYP11A1—uterine cancer	0.000112	0.00417	CbGpPWpGaD
Paramethadione—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000111	0.00414	CbGpPWpGaD
Paramethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000111	0.00412	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—SMAD3—uterine cancer	0.000109	0.00407	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—AKR1C3—uterine cancer	0.000106	0.00393	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—GPX3—uterine cancer	0.000104	0.00388	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	9.91e-05	0.00369	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—VEGFA—uterine cancer	9.91e-05	0.00369	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—CYP11A1—uterine cancer	9.81e-05	0.00365	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—NRAS—uterine cancer	9.79e-05	0.00364	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—CYP11A1—uterine cancer	9.68e-05	0.0036	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	9.66e-05	0.00359	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—ERBB2—uterine cancer	9.49e-05	0.00353	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	9.34e-05	0.00347	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—MET—uterine cancer	9.26e-05	0.00345	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—ERBB2—uterine cancer	9.19e-05	0.00342	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—ERBB2—uterine cancer	9.18e-05	0.00342	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—AKR1C3—uterine cancer	9.14e-05	0.0034	CbGpPWpGaD
Paramethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	9e-05	0.00335	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—MET—uterine cancer	8.97e-05	0.00334	CbGpPWpGaD
Paramethadione—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	8.88e-05	0.0033	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	8.71e-05	0.00324	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	8.68e-05	0.00323	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	8.48e-05	0.00316	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—KRAS—uterine cancer	8.43e-05	0.00314	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—CYP19A1—uterine cancer	8.35e-05	0.00311	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—CYP19A1—uterine cancer	8.24e-05	0.00306	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—CTNNB1—uterine cancer	8.03e-05	0.00299	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	7.99e-05	0.00297	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	7.88e-05	0.00293	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—EP300—uterine cancer	7.47e-05	0.00278	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	7.44e-05	0.00277	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—VEGFA—uterine cancer	7.31e-05	0.00272	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	7.29e-05	0.00271	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	7.22e-05	0.00269	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—NRAS—uterine cancer	7.22e-05	0.00269	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—HRAS—uterine cancer	7.16e-05	0.00266	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	7.12e-05	0.00265	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	7.09e-05	0.00264	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—VEGFA—uterine cancer	7.08e-05	0.00263	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—VEGFA—uterine cancer	7.07e-05	0.00263	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—NRAS—uterine cancer	6.99e-05	0.0026	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—NRAS—uterine cancer	6.99e-05	0.0026	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—ERBB2—uterine cancer	6.77e-05	0.00252	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—ERBB2—uterine cancer	6.56e-05	0.00244	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	6.37e-05	0.00237	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.3e-05	0.00234	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.3e-05	0.00234	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—KRAS—uterine cancer	6.21e-05	0.00231	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—KRAS—uterine cancer	6.02e-05	0.00224	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—KRAS—uterine cancer	6.01e-05	0.00224	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—CTNNB1—uterine cancer	5.92e-05	0.0022	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	5.88e-05	0.00219	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	5.79e-05	0.00216	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—CTNNB1—uterine cancer	5.74e-05	0.00213	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	5.59e-05	0.00208	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—EP300—uterine cancer	5.51e-05	0.00205	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—EP300—uterine cancer	5.33e-05	0.00198	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—HRAS—uterine cancer	5.28e-05	0.00196	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	5.27e-05	0.00196	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—VEGFA—uterine cancer	5.21e-05	0.00194	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	5.19e-05	0.00193	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—NRAS—uterine cancer	5.15e-05	0.00192	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.12e-05	0.00191	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.12e-05	0.00191	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—HRAS—uterine cancer	5.11e-05	0.0019	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—HRAS—uterine cancer	5.11e-05	0.0019	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—VEGFA—uterine cancer	5.05e-05	0.00188	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—NRAS—uterine cancer	4.99e-05	0.00186	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	4.91e-05	0.00183	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.62e-05	0.00172	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—AKT1—uterine cancer	4.51e-05	0.00168	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—SRD5A2—uterine cancer	4.49e-05	0.00167	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—NDUFB11—uterine cancer	4.49e-05	0.00167	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—KRAS—uterine cancer	4.43e-05	0.00165	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—KRAS—uterine cancer	4.29e-05	0.0016	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—NDUFB11—uterine cancer	3.88e-05	0.00144	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—SRD5A2—uterine cancer	3.88e-05	0.00144	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	3.87e-05	0.00144	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	3.82e-05	0.00142	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—HRAS—uterine cancer	3.77e-05	0.0014	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.77e-05	0.0014	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.76e-05	0.0014	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—HRAS—uterine cancer	3.65e-05	0.00136	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.56e-05	0.00132	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—AKT1—uterine cancer	3.33e-05	0.00124	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—AKR1B1—uterine cancer	3.24e-05	0.00121	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—STAR—uterine cancer	3.24e-05	0.00121	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—AKT1—uterine cancer	3.22e-05	0.0012	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—SRD5A2—uterine cancer	3.16e-05	0.00117	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—NDUFB11—uterine cancer	3.16e-05	0.00117	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.07e-05	0.00114	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.9e-05	0.00108	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—AKR1B1—uterine cancer	2.8e-05	0.00104	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—STAR—uterine cancer	2.8e-05	0.00104	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.77e-05	0.00103	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—POLD1—uterine cancer	2.55e-05	0.000947	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—AKR1C1—uterine cancer	2.38e-05	0.000886	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—STAR—uterine cancer	2.28e-05	0.000849	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—AKR1B1—uterine cancer	2.28e-05	0.000849	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.26e-05	0.000839	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—POLD1—uterine cancer	2.2e-05	0.000819	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—RRM2—uterine cancer	2.12e-05	0.00079	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.08e-05	0.000775	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.08e-05	0.000775	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—DCN—uterine cancer	2.06e-05	0.000767	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—AKR1C1—uterine cancer	2.06e-05	0.000766	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CYP11A1—uterine cancer	1.94e-05	0.000722	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—RRM2—uterine cancer	1.83e-05	0.000683	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—AKR1C3—uterine cancer	1.83e-05	0.000682	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—POLD1—uterine cancer	1.79e-05	0.000666	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—DCN—uterine cancer	1.78e-05	0.000663	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.68e-05	0.000624	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.68e-05	0.000623	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.58e-05	0.00059	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—STAR—uterine cancer	1.51e-05	0.00056	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.51e-05	0.00056	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—RRM2—uterine cancer	1.49e-05	0.000556	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—DCN—uterine cancer	1.45e-05	0.000539	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—STK11—uterine cancer	1.43e-05	0.000531	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CYP19A1—uterine cancer	1.43e-05	0.000531	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.37e-05	0.000508	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.29e-05	0.00048	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—STK11—uterine cancer	1.23e-05	0.000459	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.23e-05	0.000459	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—POLD1—uterine cancer	1.18e-05	0.00044	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.16e-05	0.000431	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.11e-05	0.000411	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.1e-05	0.000411	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—MTHFR—uterine cancer	1.07e-05	0.000399	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CYP19A1—uterine cancer	1e-05	0.000374	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—STK11—uterine cancer	1e-05	0.000374	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—RRM2—uterine cancer	9.85e-06	0.000366	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—DCN—uterine cancer	9.56e-06	0.000356	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.43e-06	0.000351	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—MTHFR—uterine cancer	9.28e-06	0.000345	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CYP11A1—uterine cancer	9.01e-06	0.000335	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.99e-06	0.000335	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—AKR1C3—uterine cancer	8.51e-06	0.000316	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.18e-06	0.000304	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—MTHFR—uterine cancer	7.55e-06	0.000281	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.65e-06	0.000248	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CYP19A1—uterine cancer	6.63e-06	0.000247	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—STK11—uterine cancer	6.63e-06	0.000247	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—PTEN—uterine cancer	5.97e-06	0.000222	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—EP300—uterine cancer	5.69e-06	0.000212	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—PTEN—uterine cancer	5.16e-06	0.000192	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—MTHFR—uterine cancer	4.98e-06	0.000185	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—EP300—uterine cancer	4.92e-06	0.000183	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—PIK3CA—uterine cancer	4.21e-06	0.000157	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—PTEN—uterine cancer	4.2e-06	0.000156	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—EP300—uterine cancer	4.01e-06	0.000149	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—PIK3CA—uterine cancer	3.64e-06	0.000135	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—AKT1—uterine cancer	3.44e-06	0.000128	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—AKT1—uterine cancer	2.97e-06	0.000111	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.96e-06	0.00011	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—PTEN—uterine cancer	2.77e-06	0.000103	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—EP300—uterine cancer	2.64e-06	9.83e-05	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—AKT1—uterine cancer	2.42e-06	9.01e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.95e-06	7.27e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—AKT1—uterine cancer	1.6e-06	5.94e-05	CbGpPWpGaD
